WE 941 OD

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WE 941 OD, covering 2014-08-18 to 2014-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) in Healthy Adult Males [Phase 1]